Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.57 USD | +1.29% | +9.79% | -20.30% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 12.13M | Capitalization | 25.79M |
---|---|---|---|---|---|
Net income 2024 * | -38M | Net income 2025 * | -19M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.13 x |
P/E ratio 2024 * |
-0.67
x | P/E ratio 2025 * |
-1.52
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.48% |
Latest transcript on Iterum Therapeutics plc
1 day | +1.29% | ||
1 week | +9.79% | ||
Current month | +1.95% | ||
1 month | +1.29% | ||
3 months | -5.43% | ||
6 months | +141.50% | ||
Current year | -20.30% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Dunne
FOU | Founder | 64 | 15-10-31 |
Corey N. Fishman
FOU | Founder | 59 | 15-06-23 |
Director of Finance/CFO | 54 | 15-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ron Hunt
CHM | Chairman | 59 | 15-10-31 |
Beth Hecht
BRD | Director/Board Member | 60 | 21-03-11 |
Corey N. Fishman
FOU | Founder | 59 | 15-06-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.57 | +1.29% | 50,986 |
24-04-24 | 1.55 | -1.90% | 36,019 |
24-04-23 | 1.58 | 0.00% | 42,680 |
24-04-22 | 1.58 | +10.49% | 197,643 |
24-04-19 | 1.43 | 0.00% | 60,950 |
Delayed Quote Nasdaq, April 25, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.30% | 25.79M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+46.73% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- ITRM Stock